Back to CIBC Bancorp USA Inc. CIBC Bancorp USA Inc.

ABCLABCL

2 quarters

Position history for CIBC Bancorp USA Inc.CIBC Bancorp USA Inc.'s holdings in AbCellera Biologics Inc.

No. CIBC Bancorp USA exited its ABCL (AbCellera Biologics) position in Q2 2026. Its Q1 2026 13F listed 20,000 shares worth $69,800. CIBC Bancorp USA first reported ABCL in Q1 2026 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$69,800

Total Shares Change

-20,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$7.85
0
2026-Q1
New
20,000
—
$69,8000.0%$3.49
29

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used